ClinicalTrials.gg
Not yet recruitingNCT05197998Updated Oct 26, 2026

Leveraging Families to Promote Healthy Socio-Emotional Development in Children

An interventional study of ColorBRAVE in Child Development, Parents and Prosocial and Emotional Well-Being, sponsored by Tulane University. Not yet recruiting at 1 site in United States. Open to participants aged 5 Years to 100 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-26.

Sponsored by Tulane University · Not applicable, Interventional, and Prevention

How we know

Updated Oct 26, 2026Now Not yet recruitingStart date moved+3 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
1,200
Allocation
Randomized
Ages
5 Years to 100 Years
Sex
All
01

Study summary

The objective of this research is to evaluate a mobile app-based intervention for parents of children in K-2nd grade designed that guides them in how to have productive conversations about race with their children. This study will recruit a national sample of parents and their K-2nd grade children. The impact of the intervention is tested using a wait-list controlled trial design. Outcomes include prosocial behaviors and indicators of emotional well-being.

02

Conditions studied

  • Child Development
  • Parents
  • Prosocial and Emotional Well-Being
03

In context

Lead sponsor

Tulane University is the lead sponsor of 96 studies on the registry; 23 are open to participants now.

Of its 9 completed or terminated interventional studies of FDA-regulated products, 5 (56%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
5 Years to 100 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

Residence in the US; caregiver age 18 years or older and child age 5-8 years old; ability to read and understand English

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
1,200 participants (estimated)

Study arms

  • Experimental
    ColorBRAVE

    The experimental group will be asked to download a multi-module mobile app designed to guide parents and caregivers in having conversations about race with their K-2nd grade children

    Behavioral: ColorBRAVE

  • Other
    Wait-list Control

    The wait-list control group will be placed on the wait-list for the first 6-weeks, the period in which the experimental group will complete the intervention program. Following the 6-week wait-list period they will receive the ColorBRAVE program.

    Behavioral: ColorBRAVE

Interventions

  • BehavioralColorBRAVE

    The intervention is a multi-module program delivered via a mobile app for parents of children in K-2nd grade. Each module in the program will take approximately 30 minutes to complete, with lessons facilitated through interactive storytelling, videos, and games.

06

What researchers measure

Primary outcomes

  1. Racial Socialization Frequency Scale

    Parents will report the frequency with which they engage in racial socialization practices with their K-2nd grade child.

    Time frame: 0-12 months

  2. Racial Socialization Competency Scale

    Parents will report the degree of comfort, skills, and stress in engaging in different processes related to racial socialization with their K-2nd grade child.

    Time frame: 0-12 months

  3. Cross-race Friendships

    Parents will report the race of their K-2nd grade child's 5 closest friends - the number of cross-race friendships will consist of the number of friends that are race discordant to their child.

    Time frame: 0-12 months

  4. Colorblind Racial Attitudes (CoBRAS) Scale

    Color-blind racial attitudes among parents will be assessed using the COBRAS Scale.

    Time frame: 0-12 months

  5. Child Prosocial Behavior Questionnaire (CPBQ)

    Parents will report on the degree to which their K-2nd grade child engages in various prosocial behaviors, including those surrounding helping, sharing, and comforting.

    Time frame: 0-12 months

  6. Patient-Reported Outcomes Measurement Information System (PROMIS) Parent Proxy Measures

    Parent reports of child socio-emotional well being (e.g., positive peer relationships, depression, anxiety).

    Time frame: 0-12 months

  7. Prosocial Children Measure

    Children (ages 5-8 years old) will be introduced to a child and told scenarios in which that child must choose other children to engage in various activities with, among a group of diverse children. Children will be asked (1) whether they liked or disliked how that child chose the children to participate in the activity with and (2) if there is anything they would like to say to that child about their choice in children.

    Time frame: 0-12 months

  8. Child Bystander Response Questionnaire

    Children will report the frequency with which they engage in different bystander behaviors when they see someone being treated poorly or unfairly due to their race, ethnicity, or cultural background.

    Time frame: 0-12 months

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: Yes — Upon completion of key analyses, study documentation and de-identified data will be made available to the research community upon request. Data requests may be submitted to the Project Coordinator and reviewed by the study PI to determine whether there is significant scientific overlap in the research questions and analyses proposed by the outside investigator. Those who submit qualified proposals will be provided with a dataset containing only the variables requested and the associated documentation (e.g., codebooks, description of study protocols, data dictionaries) under a data sharing agreement.

No publications or documents are linked to this record.

09

Timeline

2 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it moved

Start is estimated for Feb 2027; primary completion for May 2027, 3 months later.

Start moved twice since we started tracking on Sep 25, 2026: Aug 2026 → Feb 2027, last on Oct 26, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Nov 22, 2021
First posted
Jan 20, 2022
StartEst.
Feb 1, 2027was Aug 2026
Primary completionEst.
May 31, 2027
CompletionEst.
May 31, 2027
Last update
Oct 26, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Suspended→Not yet recruiting Reason for stopping removed
changed Oct 13, 2026
Start date
Aug 1, 2026→Feb 1, 2027
moved 2 times, Oct 13, 2026 – Oct 26, 2026
Contact
Study contact now listed: added d•••@tulane.edu · •••1847. See the current contact
Oct 13, 2026
Site contacts
Changed at 1 site. See the sites
Show the site
  • Tulane University · New Orleans, United StatesContact added d•••@tulane.edu · •••1847
Oct 13, 2026
Title
Promoting ColorBRAVE Conversations in Families→Leveraging Families to Promote Healthy Socio-Emotional Development in Children
Oct 26, 2026
Sponsor
Collaborators added: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Oct 26, 2026
Show all 2 updates
  1. Oct 26, 2026
    Start date Dec 1, 2026→Feb 1, 2027
    Sponsor Collaborators added: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
    Title Promoting ColorBRAVE Conversations in Families→Leveraging Families to Promote Healthy Socio-Emotional Development in Children
  2. Oct 13, 2026
    Suspended→Not yet recruiting
    Why stopped Reason for stopping removed
    Start date Aug 1, 2026→Dec 1, 2026
    Contact Study contact now listed: added d•••@tulane.edu · •••1847. See the current contact
    Site contacts Changed at 1 site. See the sites
    Show the site
    • Tulane University · New Orleans, United StatesContact added d•••@tulane.edu · •••1847
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT05197998
Lead sponsor
Tulane University
Responsible party
Sponsor
First posted
Jan 20, 2022
Start date
Feb 1, 2027 (estimated)
Primary completion
May 31, 2027 (estimated)
Completion
May 31, 2027 (estimated)
Last update
Oct 26, 2026

Study contacts

David H. Chae, ScD, MA
Contact
dchae@tulane.edu
504-988-1847
David H. Chae, ScD, MA
principal investigator · Tulane University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion